Tavin EM Tablets contain Tenofovir Disoproxil Fumarate and Emtricitabine, a fixed-dose combination of two nucleoside reverse transcriptase inhibitors (NRTIs) used in antiretroviral therapy. It works by blocking reverse transcriptase, an enzyme required for HIV replication, helping reduce viral activity and support effective management of HIV infection.

Benefits

• Helps manage HIV-1 infection as part of combination therapy
• Supports reduction of viral replication
• Helps maintain immune system function
• Provides convenient fixed-dose antiviral treatment
• Supports consistent long-term HIV management when taken correctly

Active Ingredient

Tenofovir Disoproxil Fumarate + Emtricitabine

Pack Size

30 Tablets

Indications

Tavin EM is indicated for use as part of combination antiretroviral therapy for the treatment of HIV-1 infection and may be prescribed for HIV pre-exposure prophylaxis (PrEP) in eligible individuals. It should only be used under the supervision of a qualified healthcare professional.

Directions for Use

Take Tavin EM exactly as prescribed by your healthcare provider. Swallow the tablet whole with water, with or without food, and take it consistently at the same time each day. Continue treatment for the duration recommended and do not stop without medical guidance.